F2G

is an England-based clinical-stage biopharmaceutical company that discovers and develops novel therapies for the treatment of rare fungal diseases...
Read more
F2G CEO: Francesco Maria Lavino

CEO

Francesco Maria Lavino

CEO Approval Rating

90/100

Est. Annual Revenue
$100-500M
Agree?
Est. Employees
25-100
Agree?
Funding
$369.6M

F2G Competitors

1Cidara Therapeutics
2Amplyx
3SCYNEXIS
4Basilea
5Entasis
6Viamet Pharma
7Fate Therapeutics
8NexImmune
9LEO Pharma
10Iovance

Trending Companies